✦ LIBER ✦

P233 Adalimumab produces high responder and remission rates and has an independent effect on quality of life in Crohn's disease patients

✍ Scribed by J. Mudter; M.F. Neurath; P. von Arnauld de la Perriére; N. Teich; H. Hartmann; G. Manok; M. Schwarz; B.M. Wittig

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P055 - The ACCESS trial: impact of adali

✍ R. Panaccione; E.V. Loftus Jr.; D. Binion; K. McHugh; N. Chen; B. Guérette; P. M 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 50 KB

P038 - Adalimumab sustains remission and

✍ E.V. Loftus Jr.; D.T. Rubin; N. Chen; J. Chao; P. Mulani 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 51 KB

P254 Effect of standard treatment (ST) v

✍ S. Odes; H. Vardi; D. Greenberg; M. Friger; R. Stockbrugger; B. Moum; C. O'Morai 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 120 KB